Health ❯ Healthcare ❯ Pharmaceuticals

Regulatory Affairs

FDA FDA Approval Quality Control Drug Approval Marketing Authorization FDA Compliance FDA Approvals Anvisa International Standards FDA Approval Process Drug Regulation Clinical Trials Good Manufacturing Practices FDA Enforcement FDA Regulations EMA Recommendations Clinical Trial Results Pharmacovigilance Marketing Authorisation FDA Recall Drug Recall European Medicines Agency Drug Development Medication Safety Counterfeit Products Pharma Accountability FDA Actions ANSM Regulations Label Updates FDA Rejection NDMA Contamination

FDA Adds Brain Tumor Warning to Two Depo‑Provera Injections

The update follows overseas safety actions and arrives as Pfizer confronts lawsuits from more than 1,000 women over alleged failures to warn.

Terns’ TERN-701 Shows Strong CML Responses in CARDINAL, Setting 320 mg and 500 mg Phase 2 Doses

FDA Accepts Sonrotoclax NDA, Grants Priority Review for Relapsed Mantle Cell Lymphoma

Sarepta Shares Plunge After ESSENCE Phase 3 Miss in Duchenne Trial

EU Regulators Back Libtayo as Adjuvant Therapy for High-Risk Cutaneous Squamous Cell Carcinoma

Savara Investors Pressed to Seek Lead Role in Securities Suit Before Nov. 7 Deadline